Created at 6:27 p.m. Mar, 27, 2025
Author: ansleywallace12
Related Note: 1485037181746 2
Rationale for change

although it specifies that benzos are used for acute panic symptoms in the extra tab, it would be helpful to clarify that the question is asking about long-term managment rather than an acute exacerbation of panic disorder

not totally necessary given the current phrasing of the question but would be helpful

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::05_SNRIs #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #AK_Step2_v12::Original_decks::Dorian::psych::uw #AK_Step3_v12::#NBME::Form7::Section_2 #AK_Step1_v12::^Systems::Psychiatry #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::zanki #AK_Step2_v12::#Subjects::Psychiatry::01_Anxiety_Disorders::Panic_Disorder::Management #AK_Step1_v12::#AMBOSS::#Self_Assessment #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::dorian #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::01_SSRIs #PANCE::EOR::PEDS #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::20_SNRIs #AK_Step1_v12::#AMBOSS::JSas04 #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Step2_v12::Original_decks::Zanki_Step_2::Psych::UW_Psych #AK_Step1_v12::#FirstAid::13_Psych::02_Pathology::20_Panic_disorder #AK_Step1_v12::#UWorld::COMLEX::24554 #AK_Step1_v12::#UWorld::COMLEX::25724 #AK_Step2_v12::#Subjects::Psychiatry::01_Anxiety_Disorders::Panic_Disorder #AK_Step2_v12::#UWorld::Step::14970 #AK_Step2_v12::#AMBOSS #AK_Step1_v12::#UWorld::Step::1443 #AK_Step2_v12::#OME::04_Psychiatry::15_Psych_Pharm_2 #AK_Step2_v12::#Resources_by_rotation::Psych::emma #AK_Step2_v12::#UWorld::#UWSA2 #AK_Step2_v12::#NBME::Form12 #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::02_Anxiolytic_and_Hypnotic_Drugs #AK_Step2_v12::Original_decks::Dorian::psych::emma #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::02_Antidepressants_&_Anxiolytics::01_SSRIs,_SNRIs,_Cyproheptadine #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm #AK_Step2_v12::#UWorld::Step::12307 #AK_Step2_v12::#AMBOSS::_705oh #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::19_SSRIs #PANCE::BEHAVIORAL::anxiety_disorders #AK_Step2_v12::#SketchyPsych::02_Anxiety_Disorders::02_Panic_Disorders::01_Panic_Disorder #AK_Step2_v12::#UWorld::COMLEX::102754 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Physeo::07_Psychiatry::02_Psychiatry::06_Anxiety_Disorders #AK_Step1_v12::#UWorld::Step::11838 #PANCE::EOR::PSYCH #AK_Step1_v12::#UWorld::Step::11756 #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::07_Selective_serotonin_reuptake_inhibitors #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step2_v12::#OME::04_Psychiatry::01_Anxiety_Disorders #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step1_v12::#Bootcamp::Psychiatry::04_Anxiety_Trauma_and_Stress_Disorders::01_Anxiety_and_Panic_Disorders #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::08_Serotonin-norepinephrine_reuptake_inhibitors #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::06_Antidepressants::*Preferred_Medications_For_Selected_Psychiatric_Conditions